SRC and metastatic malignant neoplasm: The STAT3 oncogene is required as a downstream effector of SRC and promotes invasive phenotypes by suppressing p53 and p53-inducible protein caldesmon, an antagonist of podosome, which was found especially in invasive SRC-transformed cells in the context of metastatic cancer cells [105,106].